SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-19-000352
Filing Date
2019-08-29
Accepted
2019-08-29 17:28:03
Documents
64
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rgbp033119form10q.htm 10-Q 1400851
2 EXHIBIT 10.5 ex10_5.htm EX-10.5 49242
3 EXHIBIT 10.6 ex10_6.htm EX-10.6 56357
4 EXHIBIT 10.7 ex10_7.htm EX-10.7 54125
5 EXHIBIT 10.8 ex10_8.htm EX-10.8 60538
6 EXHIBIT 10.9 ex10_9.htm EX-10.9 10404
7 EXHIBIT 31.1 ex31_1.htm EX-31.1 8154
8 EXHIBIT 31.2 ex31_2.htm EX-31.2 8210
9 EXHIBIT 32.1 ex32_1.htm EX-32.1 4815
10 EXHIBIT 32.2 ex32_2.htm EX-32.2 4816
  Complete submission text file 0001607062-19-000352.txt   5476074

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE rgbp-20190331.xml EX-101.INS 993193
12 XBRL SCHEMA FILE rgbp-20190331.xsd EX-101.SCH 60800
13 XBRL CALCULATION FILE rgbp-20190331_cal.xml EX-101.CAL 45517
14 XBRL DEFINITION FILE rgbp-20190331_def.xml EX-101.DEF 200339
15 XBRL LABEL FILE rgbp-20190331_lab.xml EX-101.LAB 279440
16 XBRL PRESENTATION FILE rgbp-20190331_pre.xml EX-101.PRE 257294
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 191067342
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences